Prof. Dan Yan, Beijing Friendship Hospital, Capital Medical University, China China
Prof. Dan Yan is the Director of the Pharmacy Department and Vice Director of the Drug Clinical Trial Institution at Beijing Friendship Hospital, Capital Medical University. A leading expert in intelligent molecular diagnosis and combination therapies for chronic metabolic diseases, he has authored numerous high-impact publications and led national research projects. With a Ph.D. from Chengdu University of Traditional Chinese Medicine and postdoctoral training in cell biology, Prof. Yan also serves on key national academic committees. He work bridges traditional Chinese medicine with modern pharmacology to advance precision healthcare.
Publication Profile
Scopus
Education
Prof. Dan Yan 🎓 has dedicated he academic journey to the field of Traditional Chinese Medicine. He earned he Ph.D. (2004–2007), M.S. (2001–2004), and B.S. (1994–1998) degrees—all from the esteemed Chengdu University of Traditional Chinese Medicine 🏛️. He consistent pursuit of knowledge over the years reflects a deep passion for advancing holistic health and medical science rooted in ancient wisdom 🌿. With a strong foundation in both theoretical and practical aspects of Traditional Chinese Medicine, Prof. Yan continues to contribute significantly to research, education, and innovation in this timeless and evolving discipline 📚🔬.
Experience
Prof. Dan Yan 🌟 has actively served on numerous prestigious academic committees, showcasing he leadership in Traditional Chinese Medicine. Since 2023, he has been recognized as a National High-level Leading Talent 🇨🇳, Director of a Key Discipline under the National Administration of TCM 🏛️, and a recipient of the Chinese Government Special Allowance 🏅. He is also a member of the China National Pharmacopoeia Committee (2022–2027) 📘 and holds leadership roles in institutes focused on clinical pharmacy, precision medicine, and rational drug use 💊📊. He extensive contributions highlight he dedication to advancing science, policy, and international collaboration in healthcare 🌐🧬.
Research Focus
Prof. Dan Yan is a leading researcher in metabolic diseases, particularly focusing on type 2 diabetes, insulin resistance, and gut microbiota 🧫. He research integrates microbiome science, metabolomics, and traditional Chinese medicine🌿 to develop novel therapeutic strategies. He investigates microbial metabolites (e.g., succinate, L-citrulline) and their roles in modulating intestinal immunity🦠 and enhancing drug responses like metformin efficacy💊. He studies also include chemodynamic therapy, biomarker discovery, and machine learning-based screening in diabetes diagnostics 🤖. Prof. Yan’s contributions are reshaping how we understand and manage chronic metabolic disorders on a molecular and systemic level.
Publication Top Notes
Lactobacillus murinus alleviates insulin resistance via promoting L-citrulline synthesis
Function, mechanism of action, metabolism, and commercial application of Lonicera japonica: a review
Coupling Probiotics with CaO2 Nanoparticle-Loaded CoFeCe-LDH Nanosheets to Remodel the Tumor Microenvironment for Precise Chemodynamic Therapy
Microbial succinate promotes the response to metformin by upregulating secretory immunoglobulin a in intestinal immunity
Circulating metabolites difference in type 2 diabetes patients from regions: a cross-sectional study
Detecting key genes relative expression orderings as biomarkers for machine learning-based intelligent screening and analysis of type 2 diabetes mellitus
Advances in in vitro assessment models and screening methods for blood glucose-lowering medications
Discovery of the targets and lead compounds of traditional chinese medicine based on the molecular trajectory of diabetes evolution
3D spheroid HepaRG and fluorescent biphasic tracer for CYP3A4-mediated antibiotic interaction monitoring in sepsis
Integrated biomarker profiling for predicting the response of type 2 diabetes to metformin